Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. It is available from three suppliers. There are twelve…
The post New patent for Norton Waterford drug QVAR REDIHALER app…
New patent for Norton Waterford drug QVAR REDIHALER Read Post »
Acetylcysteine is the generic ingredient in seven branded drugs marketed by Cumberland Pharms, Aspen, Eugia Pharma, Exela Pharma, Fresenius Kabi Usa, Indoco, Rising, Sagent Pharms Inc, Steriscience, Zydus Pharms, Alvogen,…
The post New tentative approv…
New tentative approval for Rising drug acetylcysteine Read Post »
Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPaten…
Annual Drug Patent Expirations for VYNDAQEL Vyndaqel is a drug marketed by Foldrx Pharms and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Foldrx Pharms drug VYNDAQEL appeared first on DrugPa…
Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Ucb Inc drug FINTEPLA appeared first on DrugPatentWatch …
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twenty-six patents protecting…
The post New patent for Abbvie drug RINVOQ appeared first on DrugPaten…
Annual Drug Patent Expirations for DALVANCE Dalvance is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Abbvie drug DALVANCE appeared first o…
Annual Drug Patent Expirations for AMRIX Amrix is a drug marketed by Teva Pharms Intl and is included in one NDA. It is available from seven suppliers. There are eight…
The post New patent expiration for Teva Pharms drug AMRIX appeared first on DrugPat…
New patent expiration for Teva Pharms drug AMRIX Read Post »
This chart shows the pharmaceutical companies with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Finland? Read Post »
AMRIX (cyclobenzaprine hydrochloride) Teva pharms intl Patent: 7,829,121 Expiration: Nov 14, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expira…
Drug Patent Expirations for the Week of November 12, 2023 Read Post »
Get new actionable insights and updates from BiotechBlog
